1,117
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Patched and Costal-2 mutations lead to differences in tissue overgrowth autonomy

, , , , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 176-189 | Received 22 Jun 2021, Accepted 02 Apr 2022, Published online: 25 Apr 2022
 

ABSTRACT

Genetic screens are used in Drosophila melanogaster to identify genes key in the regulation of organismal development and growth. These screens have defined signalling pathways necessary for tissue and organismal development, which are evolutionarily conserved across species, including Drosophila. Here, we have used an FLP/FRT mosaic system to screen for conditional regulators of cell growth and cell division in the Drosophila eye. The conditional nature of this screen utilizes a block in the apoptotic pathway to prohibit the mosaic mutant cells from dying via apoptosis. From this screen, we identified two different mutants that mapped to the Hedgehog signalling pathway. Previously, we described a novel Ptc mutation and here we add to the understanding of disrupting the Hh pathway with a novel allele of Cos2. Both of these Hh components are negative regulators of the pathway, yet they depict mutant differences in the type of overgrowth created. Ptc mutations lead to overgrowth consisting of almost entirely wild-type tissue (non-autonomous overgrowth), while the Cos2 mutation results in tissue that is overgrown in both the mutant and wild-type clones (both autonomous and non-autonomous). These differences in tissue overgrowth are consistent in the Drosophila eye and wing. The observed difference is correlated with different deregulation patterns of pMad, the downstream effector of DPP signalling. This finding provides insight into pathway-specific differences that help to better understand intricacies of developmental processes and human diseases that result from deregulated Hedgehog signalling, such as basal cell carcinoma.

Acknowledgments

We thank A. Bergmann, T. Cook, and K. Moberg for Drosophila stocks and reagents. We thank T. Cook and E. Kagey for helpful comments on earlier drafts of this manuscript. Antibodies were obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242. Stocks obtained from the Bloomington Drosophila Stock Center (NIH P40OD018537) were used in this study.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability

The authors confirm that the data supporting the findings of this study are available within the article [and/or] its supplementary materials.

Supplementary material

Supplemental data for this article can be accessed here

Additional information

Funding

This work was supported by the National Science Foundation (2021146 to KLB and JDK) and the National Institutes of Health BUILD initiative ReBUILDetroit (UL1GM118982, TL4GM118983, and RL5GM118981 to JDK and SJN); National Institute of General Medical Sciences (GM103440 to RLT and KLB).